TXNRD2 and prostate carcinoma: Similar trends were observed for the TXNRD2 rs8141691 variant, where individuals with the AA allele were less likely to develop high-grade prostate cancer risk with selenium supplementation, while those with the GG and AG alleles had an increased risk of high-grade prostate cancer [16].